Human papillomavirus testing for primary cervical cancer screening

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer is a significant global health issue, particularly in Europe.
• Papanicolaou (Pap) smear screening prevents most cervical cancer deaths, but advancements are needed.
• Human papillomavirus (HPV) infection is the primary cause of cervical cancer.

Purpose of the Study:

• To review recent advances in HPV testing for cervical cancer prevention.
• To evaluate the efficacy of HPV testing as a primary screening tool.
• To explore the integration of HPV testing into current screening algorithms.

Main Methods:

• Review of large-scale randomized controlled trials on HPV testing.
• Comparison of HPV testing with Papanicolaou (Pap) smear in detecting cervical lesions.
• Analysis of screening algorithms involving HPV testing and cytology triage.

Main Results:

• HPV testing detects approximately 50% more high-grade cervical lesions than Pap tests.
• Screening algorithms using HPV testing with cytology triage maintain high specificity.
• HPV testing offers advantages such as objectivity, automation, and cost-saving potential.

Conclusions:

• HPV testing is a highly sensitive method for detecting high-grade cervical lesions.
• Integrating HPV testing into primary cervical cancer screening programs is a viable strategy.
• Further evaluation of HPV testing algorithms is recommended for global cervical cancer prevention efforts.